Emodin
Spezifikationen
518-82-1CAS-Nummer
208-258-8EG-Nummer
1,3,8-trihydroxy-6-methylanthracene-9,10-dioneIUPAC-Name
C15H10O5Chemische Formel
270.24 g/molMolekulargewicht
emodin; 518-82-1; Emodol; Frangula emodin; 1,3,8-trihydroxy-6-methylanthracene-9,10-dione; Schuttgelb; Rheum emodin; Archin; Frangulic acid; 3-Methyl-1,6,8-trihydroxyanthraquinone; Persian Berry Lake; 1,3,8-Trihydroxy-6-methylanthraquinone; 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione; 9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl-; 6-Methyl-1,3,8-trihydroxyanthraquinone; C.I. Natural Yellow 14; 1,3,8-Trihydroxy-6-methyl-9,10-anthraquinone; 4,5,7-Trihydroxy-2-methylanthraquinone; C.I. 75440; DTXSID5025231; KA46RNI6HN; Anthraquinone, 1,3,8-trihydroxy-6-methyl-; NSC408120; 1,3,8-Trihydroxy-6-methylanthra-9,10-quinone; NSC-408120; NSC-622947; DTXCID205231; CHEBI:42223; Emodin, Rheum; Emodin, Frangula; RefChem:35345; 3-Methyl-1,6,8-trihydroxy-antraquinone; 208-258-8; Alatinone; Emodin (Standard); MFCD00001207; NSC 408120; NSC 622947; CHEMBL289277; Anthraquinone, 6-methyl-1,3,8-trihydroxy-; 1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracene-9,10-dione; 1,3,8-trihydroxy-6-methyl-anthracene-9,10-dione; NSC622947; 1,3,8-Trihydroxy-6-methyl-anthraquinone; 6-Methyl-1,3,8-trihydroxy-9,10-anthracenedione; EMO; Rheum-emodin; Frangulinic acid; 1,8-Trihydroxy-6-methylanthraquinone; 1,3,8-trihydroxy-6-methylanthraqunone; CAS-518-82-1; SMR000326798; CCRIS 3528; HSDB 7093; SR-01000075615; EINECS 208-258-8; UNII-KA46RNI6HN; BRN 1888141; Emdoin; AI3-38286; Rheum-emodin;; Archin;; Emodol;; Frangula emodin;; 3bqc; Frangulinic acid;; Emodin CRS; Diacerein Impurity 1; Diacerein Impurity 9; Spectrum_001954; 1f0q; 3ed0; SpecPlus_000332; EMODIN [HSDB]; 1,3,8-tri-hydroxy-6-methyl-anthra-quinone; EMODIN [USP-RS]; Spectrum2_000895; Spectrum3_000742; Spectrum4_001757; Spectrum5_000614; EMODIN [MI]; Lopac-E-7881; Emodin, analytical standard; Frangula emodin (Standard); NCIMech_000049; Lopac0_000552; BSPBio_002324; KBioGR_002234; KBioSS_002508; MLS000563068; MLS001066370; MLS004257392; MLS006011712; DivK1c_006428; SCHEMBL177689; SPBio_000710; MEGxp0_000460; orb1304909; orb3139664; SCHEMBL29359841; SCHEMBL29480997; SCHEMBL29630363; ACon1_001939; BDBM11318; KBio1_001372; KBio2_002500; KBio2_005068; KBio2_007636; KBio3_001544; 1,3,8-TRIHYDROXY-6-METHYL-9-10-ANTHRACENEDIONE; HMS2230K22; HMS3261P05; HMS3373B16; HMS3655H22; HMS5080J06; EX-A6778; TNP00318; 9, 1,3,8-trihydroxy-6-methyl-; Tox21_202999; Tox21_303218; Tox21_500552; CCG-35263; EBC-11088; HY-14393R; LMPK13040008; MSK000574; s2295; SBB066133; 3-Methyl-1,8-trihydroxyanthraquinone; 4,7-Trihydroxy-2-methylanthraquinone; AKOS003348641; AC-1004; CS-1412; DB07715; FE09969; KS-5189; LP00552; SDCCGSBI-0050535.P004; SDCCGSBI-0050535.P008; Anthraquinone,3,8-trihydroxy-6-methyl-; SMP2_000211; NCGC00015420-01; NCGC00015420-02; NCGC00015420-03; NCGC00015420-04; NCGC00015420-05; NCGC00015420-06; NCGC00015420-07; NCGC00015420-08; NCGC00015420-09; NCGC00015420-11; NCGC00015420-12; NCGC00015420-22; NCGC00091540-01; NCGC00091540-02; NCGC00091540-03; NCGC00091540-04; NCGC00091540-05; NCGC00257090-01; NCGC00260544-01; NCGC00261237-01; HY-14393; NCI60_003906; ST055355; SY050737; 6-methyl-1,3,8-tri-hydroxy-anthra-quinone; E5057; EU-0100552; NS00014575; SW219906-1; 1,8-Trihydroxy-6-methyl-9,10-anthraquinone; Emodin, from Frangula bark, >=90% (HPLC); E 7881; EN300-179559; K00056; Emodin; 6-Methyl-1,3,8-trihydroxyanthraquinone; 1,3, 8-Trihydroxy-6-methyl-9,10-anthraquinone; 1,3,8-Trihydroxy-6-methylanthra-9,10-quinone #; 1,6,8-trihydroxy-3-methylanthracene-9,10-dione; AC-542/20316001; F032376; Q4348178; SR-01000075615-1; SR-01000075615-6; BRD-K58685305-001-03-0; BRD-K58685305-001-20-4; 1,3,8-Trihydroxy-6-methyl-9,10-anthracenedione, 9CI; 9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl- (9CI); Emodin, United States Pharmacopeia (USP) Reference Standard; Emodin(Diacerein EP Impurity A)(Discontinued,See C4X-10819)Synonyme
